story of the week
Trastuzumab Emtansine Plus Atezolizumab in Previously Treated, HER2-Positive Advanced Breast Cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
The Lancet Oncology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Trastuzumab Emtansine Plus Atezolizumab Versus Trastuzumab Emtansine Plus Placebo in Previously Treated, HER2-Positive Advanced Breast Cancer (KATE2): A Phase 2, Multicentre, Randomised, Double-Blind Trial
Lancet Oncol 2020 Oct 01;21(10)1283-1295, LA Emens, FJ Esteva, M Beresford, C Saura, M De Laurentiis, SB Kim, SA Im, Y Wang, R Salgado, A Mani, J Shah, C Lambertini, H Liu, SL de Haas, M Patre, S LoiFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.